LRRK2 and Parkinson disease: In addition, alteration of the gut microbiota and microbial metabolites in PD patients with PRKN or LRRK2 mutation and in DJ-1-deficienct rodent models suggests an interplay between host genetics and microbiota in the pathophysiology of PD [164, 200, 201].